|
JPS4995971A
(https=)
*
|
1973-01-27 |
1974-09-11 |
|
|
|
DE2448869A1
(de)
|
1973-10-19 |
1975-09-04 |
Mcneilab Inc |
4-oxo-2-imidazolidinylidenharnstoffe, verfahren zu ihrer herstellung und arzneimittel
|
|
US4025517A
(en)
*
|
1975-06-23 |
1977-05-24 |
Mcneil Laboratories, Incorporated |
4-Oxo-2-hexahydropyrimidinylidene ureas
|
|
JPS554305A
(en)
*
|
1978-06-13 |
1980-01-12 |
Nippon Zoki Pharmaceut Co Ltd |
Remedy for disease caused by stress and its preparation
|
|
US4864028A
(en)
|
1983-09-14 |
1989-09-05 |
Alcon Laboratories, Inc. |
Spiro-tricyclicaromatic succinimide derivatives
|
|
US5070100A
(en)
|
1983-09-14 |
1991-12-03 |
Alcon Laboratories, Inc. |
Spiro-tricyclicaromatic succinimide derivatives
|
|
GB2189698A
(en)
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated omeprazole tablets
|
|
GB2189699A
(en)
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated acid-labile medicaments
|
|
CH677886A5
(https=)
|
1989-06-26 |
1991-07-15 |
Hans Georg Prof Dr Weder |
|
|
ES2217250T3
(es)
|
1990-06-15 |
2004-11-01 |
Scios Inc. |
Mamifero transgenico, no humano que muestra la patologia de formacion amiloides de la enfermedad de alzheimer.
|
|
ES2236682T5
(es)
|
1991-01-21 |
2011-03-31 |
Elan Pharmaceuticals, Inc. |
Ensayo y modelo para la enfermedad de alzheimer.
|
|
AU671093B2
(en)
|
1992-01-07 |
1996-08-15 |
Elan Pharmaceuticals, Inc. |
Transgenic animal models for alzheimer's disease
|
|
US5604102A
(en)
|
1992-04-15 |
1997-02-18 |
Athena Neurosciences, Inc. |
Methods of screening for β-amyloid peptide production inhibitors
|
|
AU702293B2
(en)
|
1993-10-27 |
1999-02-18 |
Athena Neurosciences, Inc. |
Transgenic animals harboring APP allele having Swedish mutation
|
|
US5877399A
(en)
|
1994-01-27 |
1999-03-02 |
Johns Hopkins University |
Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
|
|
ES2094688B1
(es)
|
1994-08-08 |
1997-08-01 |
Cusi Lab |
Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
|
|
FR2730932B1
(fr)
|
1995-02-27 |
1997-04-04 |
Oreal |
Nanoemulsion transparente a base de lipides amphiphiles non-ioniques fluides et utilisation en cosmetique ou en dermopharmacie
|
|
JPH11507538A
(ja)
|
1995-06-07 |
1999-07-06 |
アテナ ニューロサイエンシズ インコーポレイティド |
β−セクレターゼ、β−セクレターゼに対する抗体、及びβ−セクレターゼ阻害を検出するためのアッセイ
|
|
US5744346A
(en)
|
1995-06-07 |
1998-04-28 |
Athena Neurosciences, Inc. |
β-secretase
|
|
FR2742676B1
(fr)
|
1995-12-21 |
1998-02-06 |
Oreal |
Nanoemulsion transparente a base de tensioactifs silicones et utilisation en cosmetique ou en dermopharmacie
|
|
FR2755854B1
(fr)
|
1996-11-15 |
1998-12-24 |
Oreal |
Nanoemulsion a base de lipides amphiphiles non-ioniques et cationiques et utilisations
|
|
FR2760970B1
(fr)
|
1997-03-18 |
2000-03-10 |
Oreal |
Nanoemulsions a base de lipides amphiphiles non-ioniques et de silicones aminees et utilisations
|
|
WO2000003819A1
(en)
|
1998-07-17 |
2000-01-27 |
The Penn State Research Foundation |
Full form roll finishing technique
|
|
PL205294B1
(pl)
|
1998-09-24 |
2010-03-31 |
Upjohn Co |
Izolowany lub oczyszczony polipeptyd, oczyszczony lub izolowany polinukleotyd, wektor, wektor ekspresyjny, komórka gospodarza, sposób wytwarzania polipeptydu, sposoby identyfikowania czynnika obniżającego, modulującego lub hamującego aktywność, zastosowanie takiego czynnika, izolowany kwas nukleinowy, obejmujący go wektor i ich zastosowanie, sposoby zmniejszania komórkowego wytwarzania beta amyloidu i zastosowanie antysensownego reagenta
|
|
FR2787027B1
(fr)
|
1998-12-14 |
2001-01-12 |
Oreal |
Nanoemulsion a base d'esters gras de sucre ou d'ethers gras de sucre et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2787026B1
(fr)
|
1998-12-14 |
2001-01-12 |
Oreal |
Nanoemulsion a base d'esters mixtes d'acide gras ou d'alcool gras, d'acide carboxylique et de glyceryle, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2787325B1
(fr)
|
1998-12-17 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras de sorbitan oxyethylenes ou non oxyethylenes, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2787326B1
(fr)
|
1998-12-17 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras de glycerol, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2787728B1
(fr)
|
1998-12-23 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras d'acide phosphorique, et ses utilisations dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
|
FR2787703B1
(fr)
|
1998-12-29 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'ethers gras ethoxyles ou d'esters gras ethoxyles, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2788007B1
(fr)
|
1999-01-05 |
2001-02-09 |
Oreal |
Nanoemulsion a base de copolymeres blocs d'oxyde d'ethylene et d'oxyde de propylene, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2788449B1
(fr)
|
1999-01-14 |
2001-02-16 |
Oreal |
Nanoemulsion a base de citrates d'alkylether, et ses utilisations dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
|
FR2789076B1
(fr)
|
1999-02-02 |
2001-03-02 |
Synthelabo |
Derives de alpha-azacyclomethyl quinoleine, leur preparation et leur application en therapeutique
|
|
US7161962B1
(en)
|
1999-05-27 |
2007-01-09 |
Nuera Communications, Inc. |
Method and apparatus for coding modem signals for transmission over voice networks
|
|
FR2811564B1
(fr)
|
2000-07-13 |
2002-12-27 |
Oreal |
Nanoemulsion contenant des polymeres non ioniques, et ses utilisations notamment dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
|
AU2002241823A1
(en)
|
2001-01-11 |
2002-07-24 |
Eastman Chemical Company |
Cyclodextrin sulfonates, guest inclusion complexes, methods of making the same and related materials
|
|
FR2819427B1
(fr)
|
2001-01-18 |
2003-04-11 |
Oreal |
Nanoemulsion translucide, son procede de fabrication et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
JP2006512401A
(ja)
|
2001-06-05 |
2006-04-13 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
ナノエマルジョンワクチン
|
|
US7476393B2
(en)
|
2002-11-29 |
2009-01-13 |
L'oreal |
Process for the preparation of a cationic nanoemulsion, and cosmetic composition
|
|
AR045219A1
(es)
|
2003-08-08 |
2005-10-19 |
Pharmacopeia Inc |
Aminas ciclicas inhibidoras de base - 1 que poseen un sustiuyente heterociclico
|
|
WO2005016876A2
(en)
|
2003-08-08 |
2005-02-24 |
Schering Corporation |
Cyclic amine bace-1 inhibitors having a benzamide substituent
|
|
US7592348B2
(en)
|
2003-12-15 |
2009-09-22 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
EP2335701B1
(en)
|
2003-12-15 |
2012-07-11 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
US7763609B2
(en)
|
2003-12-15 |
2010-07-27 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
US7468402B2
(en)
|
2004-03-17 |
2008-12-23 |
Baker Hughes Incorporated |
Polymeric nanoemulsion as drag reducer for multiphase flow
|
|
JP2008502880A
(ja)
|
2004-04-02 |
2008-01-31 |
メルク エンド カムパニー インコーポレーテッド |
アミロイド前駆体タンパク質又はβアミロイド断片に結合する物質を検出する方法及び結合化合物
|
|
US7618978B2
(en)
|
2004-04-22 |
2009-11-17 |
Eli Lilly And Company |
Amides as BACE inhibitors
|
|
IL162288A0
(en)
|
2004-06-01 |
2005-11-20 |
Future Products Man S A |
Compositions and methods for treating neurodegenerative disorders
|
|
RU2006144075A
(ru)
|
2004-06-16 |
2008-07-27 |
Вайет (Us) |
ДИФЕНИЛИМИДАЗОПИРИМИДИН И -ИМИДАЗОЛАМИНЫ КАК ИНГИБИТОРЫ β-СЕКРЕТАЗЫ
|
|
BRPI0512213A
(pt)
*
|
2004-06-16 |
2008-02-19 |
Wyeth Corp |
método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto
|
|
CA2574218A1
(en)
|
2004-07-22 |
2006-02-09 |
Schering Corporation |
Substituted amide beta secretase inhibitors
|
|
CA2575340A1
(en)
|
2004-07-28 |
2006-02-09 |
Schering Corporation |
Macrocyclic beta-secretase inhibitors
|
|
SV2006002232A
(es)
|
2004-09-21 |
2006-05-25 |
Lilly Co Eli |
Inhibidores bace ref. x-16940
|
|
GB0500683D0
(en)
|
2005-01-13 |
2005-02-23 |
Novartis Ag |
Organic compounds
|
|
KR20070102514A
(ko)
|
2005-01-13 |
2007-10-18 |
노파르티스 아게 |
Ｂａｃｅ 억제제로서 유용한 마크로시클릭 화합물
|
|
EP1896406A2
(en)
|
2005-06-14 |
2008-03-12 |
Shering Corporation |
The preparation and use of compounds as protease inhibitors
|
|
WO2006138265A2
(en)
|
2005-06-14 |
2006-12-28 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors, preparation and use thereof
|
|
ATE489370T1
(de)
|
2005-06-14 |
2010-12-15 |
Schering Corp |
Herstellung und verwendung von verbindungen als aspartylproteasehemmer
|
|
PE20070135A1
(es)
|
2005-06-14 |
2007-03-09 |
Schering Corp |
Compuestos heterociclicos como inhibidores de aspartil proteasas
|
|
AU2006259675A1
(en)
|
2005-06-14 |
2006-12-28 |
Schering Corporation |
Aspartyl protease inhibitors
|
|
KR20080025079A
(ko)
|
2005-06-14 |
2008-03-19 |
쉐링 코포레이션 |
아스파르틸 프로테아제 억제제
|
|
AR053902A1
(es)
|
2005-06-14 |
2007-05-23 |
Schering Corp |
Inhibidores de aspartil proteasa heterociclicos macrociclicos
|
|
AU2006266167A1
(en)
|
2005-06-30 |
2007-01-11 |
Wyeth |
Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation
|
|
TW200738683A
(en)
|
2005-06-30 |
2007-10-16 |
Wyeth Corp |
Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
|
|
TW200730523A
(en)
|
2005-07-29 |
2007-08-16 |
Wyeth Corp |
Cycloalkyl amino-hydantoin compounds and use thereof for β-secretase modulation
|
|
JP2009509957A
(ja)
*
|
2005-09-26 |
2009-03-12 |
ワイス |
β−セクレターゼ阻害剤としてのアミノ−５−［４−（ジフルオロメトキシ）フェニル］−５−フェニルイミダゾロン化合物
|
|
ATE478070T1
(de)
|
2005-10-27 |
2010-09-15 |
Schering Corp |
Heterozyklische aspartyl-proteasehemmer
|
|
JP2009513670A
(ja)
|
2005-10-31 |
2009-04-02 |
シェーリング コーポレイション |
アスパルチルプロテアーゼインヒビター
|
|
WO2007058601A1
(en)
*
|
2005-11-21 |
2007-05-24 |
Astrazeneca Ab |
Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia
|
|
GB0602951D0
(en)
|
2006-02-14 |
2006-03-29 |
Novartis Ag |
Organic Compounds
|
|
CN101460480A
(zh)
|
2006-04-05 |
2009-06-17 |
阿斯利康(瑞典)有限公司 |
2-氨基嘧啶-4-酮类化合物及其用于治疗或预防Aβ相关病理的用途
|
|
GB0611064D0
(en)
|
2006-06-05 |
2006-07-12 |
Novartis Ag |
Organic compounds
|
|
PE20080155A1
(es)
|
2006-06-12 |
2008-03-10 |
Schering Corp |
Compuestos heterociclicos como inhibidores de aspartil-proteasa
|
|
TW200815449A
(en)
|
2006-06-14 |
2008-04-01 |
Astrazeneca Ab |
Novel compounds II
|
|
TW200808796A
(en)
|
2006-06-14 |
2008-02-16 |
Astrazeneca Ab |
New compounds III
|
|
TW200815447A
(en)
|
2006-06-14 |
2008-04-01 |
Astrazeneca Ab |
Novel compounds IV
|
|
TW200815443A
(en)
|
2006-06-14 |
2008-04-01 |
Astrazeneca Ab |
Novel compounds I
|
|
TW200815349A
(en)
|
2006-06-22 |
2008-04-01 |
Astrazeneca Ab |
New compounds
|
|
JP2009544599A
(ja)
|
2006-07-20 |
2009-12-17 |
ノバルティス アクチエンゲゼルシャフト |
Ｂａｃｅ阻害剤として有用な大環状化合物
|
|
BRPI0715437A2
(pt)
|
2006-07-20 |
2013-04-16 |
Novartis Ag |
lactamas macrocÍclicas
|
|
JP2010522691A
(ja)
|
2006-11-23 |
2010-07-08 |
ノバルティス アーゲー |
２−ヒドロキシ−１，３−ジアミノプロパン誘導体
|
|
JP2010512389A
(ja)
|
2006-12-12 |
2010-04-22 |
シェーリング コーポレイション |
アスパルチルプロテアーゼ阻害剤
|
|
US20100016341A1
(en)
|
2006-12-12 |
2010-01-21 |
Zhaoning Zhu |
Aspartyl protease inhibitors containing a tricyclic ring system
|
|
TW200831091A
(en)
|
2006-12-20 |
2008-08-01 |
Astrazeneca Ab |
New compounds
|
|
JP2010521457A
(ja)
|
2007-03-12 |
2010-06-24 |
メルク・シャープ・エンド・ドーム・コーポレイション |
単環式アニリドスピロラクタムｃｇｒｐ受容体アンタゴニスト
|
|
CL2008000784A1
(es)
|
2007-03-20 |
2008-05-30 |
Wyeth Corp |
Compuestos amino-5-[-4-(diflourometoxi) fenil sustituido]-5-fenilmidazolona, inhibidores de b-secretasa; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar alzheimer, deterioro cognitivo, sindrome de down, disminucion co
|
|
TW200902499A
(en)
|
2007-05-15 |
2009-01-16 |
Astrazeneca Ab |
New compounds
|
|
US20090041201A1
(en)
|
2007-08-06 |
2009-02-12 |
Carestream Health, Inc. |
Alignment apparatus for imaging system
|
|
WO2009024615A1
(en)
|
2007-08-23 |
2009-02-26 |
Novartis Ag |
Aminobenzyl-substituted cyclic sulfones useful as bace inhibitors
|
|
US20090062361A1
(en)
|
2007-08-30 |
2009-03-05 |
Allergan, Inc. |
Therapeutic hydantoins
|
|
TWI431004B
(zh)
|
2008-05-02 |
2014-03-21 |
Lilly Co Eli |
Ｂａｃｅ抑制劑
|
|
KR20110050616A
(ko)
|
2008-07-10 |
2011-05-16 |
노파르티스 아게 |
Ｂａｃｅ 억제제로서 유용한 아미노벤질 치환을 갖는 시클릭 술폰
|
|
CN102186841A
(zh)
|
2008-10-22 |
2011-09-14 |
盐野义制药株式会社 |
具有bace1抑制活性的2-氨基嘧啶-4-酮及2-氨基吡啶衍生物
|
|
BRPI0823254A2
(pt)
|
2008-11-11 |
2015-06-23 |
Inst Materia Medica Cams |
Complexos de inclusão de pinocembrina com ciclodextrina ou seus derivados
|
|
AR077277A1
(es)
|
2009-07-09 |
2011-08-17 |
Lilly Co Eli |
Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer
|
|
UA108363C2
(uk)
|
2009-10-08 |
2015-04-27 |
|
Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
|
|
WO2011044187A1
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
ES2705027T3
(es)
|
2010-08-19 |
2019-03-21 |
Buck Institute For Age Res |
Métodos de tratamiento del deterioro cognitivo leve (DCL) y trastornos relacionados
|
|
US8415483B2
(en)
|
2010-12-22 |
2013-04-09 |
Astrazeneca Ab |
Compounds and their use as BACE inhibitors
|
|
US20120165346A1
(en)
|
2010-12-22 |
2012-06-28 |
Astrazeneca Ab |
Compounds and their use as BACE inhibitors
|
|
US8877744B2
(en)
|
2011-04-04 |
2014-11-04 |
Hoffmann-La Roche Inc. |
1,4-Oxazepines as BACE1 and/or BACE2 inhibitors
|
|
CA2899938C
(en)
|
2013-02-12 |
2021-10-19 |
Buck Institute For Research On Aging |
Hydantoins that modulate bace-mediated app processing
|
|
EP3341362B1
(en)
*
|
2015-08-27 |
2023-07-05 |
Nantneuro, LLC |
Compositions for app-selective bace inhibition and uses therfor
|